Evidence map›Paper›PMID 26228355›Full record

ArticleSurgery today2016

Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.

Shoji Kubo, Shigekazu Takemura, Shogo Tanaka, Takayoshi Nishioka, Masahiko Kinoshita, Genya Hamano, Tokuji Ito, Takatsugu Yamamoto, Makoto Abue, Masaru Aoki and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Shoji KuboDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. m7696493@msic.med.osaka-cu.ac.jp.
Shigekazu TakemuraDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Shogo TanakaDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Takayoshi NishiokaDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Masahiko KinoshitaDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Genya HamanoDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Tokuji ItoDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Takatsugu YamamotoDepartment of Surgery, Ishikiriseiki Hospital, Higashiosaka, Japan.
Makoto AbueDepartment of Gastroenterology, Miyagi Cancer Center, Natori, Japan.
Masaru AokiDepartment of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Kei NakagawaDivision of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Susumu HijiokaDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Atsushi MiyamotoDepartment of Surgery, National Hospital Organization, Osaka National Hospital, Osaka, Japan.
Yukio OsakiDepartment of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
Ginji EndoDepartment of Preventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shinji KumagaiDepartment of Occupational and Environmental Management, University of Occupational and Environmental Health, Kitakyushu, Japan.
Osaka City University · JPAichi Cancer Center · JPIshikiriseiki Hospital · JPMiyagi Prefectural Hospital Organization · JPNihon University · JPOsaka National Hospital · JPOsaka Red Cross Hospital · JPTohoku University · JPUniversity of Occupational and Environmental Health Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to establish an efficient strategy for screening and surveillance for occupational cholangiocarcinoma.

methodsWe evaluated the consecutive changes in laboratory findings during regular health examinations and in abdominal ultrasonography findings before the diagnosis of occupational cholangiocarcinoma in nine patients. The results of laboratory tests and abdominal ultrasonography at the time of diagnosis were also examined.

resultsIn all patients, the serum γ-glutamyl transpeptidase (γ-GTP) activity increased several years before the diagnosis of cholangiocarcinoma. The serum alanine aminotransferase (ALT) activity also increased several years before the diagnosis, following an increase in the serum aspartate aminotransferase (AST) activity in most patients. Abdominal ultrasonography before the diagnosis revealed regional dilatation of the bile ducts, which continued to enlarge. At the time of diagnosis, the γ-GTP, AST, and ALT activities were increased in nine, seven, and seven patients, respectively. The regional dilatation of bile ducts without tumor-induced stenosis, dilated bile ducts due to tumor-induced stenosis, space-occupying lesions, and/or lymph node swelling were observed. The serum concentrations of carbohydrate antigen 19-9 (CA 19-9) and/or carcinoembryonic antigen (CEA) were increased in all patients.

conclusionsRegular health examinations with a combination of ultrasonography and laboratory tests including the γ-GTP, AST, ALT, CA 19-9, and CEA levels are useful for screening and surveillance for occupational cholangiocarcinoma.

Indexed as

Early Detection of CancerAdultAlanine TransaminaseAspartate AminotransferasesBile Duct NeoplasmsBiomarkers, TumorCA-19-9 AntigenCarcinoembryonic AntigenCholangiocarcinomagamma-GlutamyltransferaseHumansMaleMiddle AgedOccupational DiseasesOccupational ExposureSolventsAlanine TransaminaseAspartate AminotransferasesBiomarkers, TumorCA-19-9 AntigenCarcinoembryonic Antigengamma-GlutamyltransferaseSolventsHealth examinationOccupational cholangiocarcinomaOrganic solventScreening and surveillance

Identifiers

PMID26228355
OpenAlexW980224068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.